Drawing for APTITUDE

USPTO serial 97977208

APTITUDE

Reviewed by CopyMark Law Group

Reg. 7329653Status 700Registered
Filing date
Status date
Registration date
Mar 12, 2024
Examiner
HESIK, APRIL ANNE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with APTITUDE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Enshan Hong

Enshan Hong MAGSTONE LAW, LLP1180 AVENUE OF THE AMERICAS, 8TH FLOORNEW YORK, NY 10036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic preparations for scientific or research use; diagnostic agents for scientific or research use; diagnostic substances for scientific or research use; chemical and biological agents, preparations, and substances for analyte detection in specimens for scientific or research useACTIVEApr 25, 2022
010An analyte detection system for medical use, comprising sample collection device, a sample preparation device, a sample analysis device, namely, a cartridge that analyzes biological samples; kits comprised of sample collection devices and sample preparation devices for medical use; healthcare diagnostic testing device for identifying the presence, absence, and quantity of particular nucleic acids, proteins, organism, or other analytes of interest within a collected sample for medical uses; medical diagnostic apparatus for testing infectious diseases, such as Covid-19, influenza, respiratory syncytial virus, strep throat, sexually transmitted infection; medical diagnostic apparatus for testing for viruses, medical diagnostic apparatus for testing bacteria; medical diagnostic apparatus for the analysis of body fluids; medical diagnostic apparatus for the analysis of biological samples; medical diagnostic apparatus for the analysis of blood samples; medical diagnostic apparatus for the analysis of plasma samples; medical diagnostic apparatus for the analysis of serum samples; medical diagnostic apparatus for the analysis of urine samples; medical diagnostic apparatus for the analysis of saliva samples; medical diagnostic apparatus for testing protein biomarkers; medical diagnostic apparatus for testing DNA or RNA biomarkers; medical diagnostic apparatus for testing small molecule biomarkersACTIVEApr 25, 2022
042Providing temporary use of online non-downloadable sample preparation and analysis software for clinical research and medical uses; Providing temporary use of online non-downloadable software for recording, logging, tracking, analyzing, and reviewing medical conditions, symptoms, ailments and/or asymptomatic conditions; Providing temporary use of online non-downloadable software for use by patients for viewing informational videos and accessing information in connection with recorded medical conditions, symptoms, ailments and/or asymptomatic conditions; Providing temporary use of online non-downloadable software for use by patients for viewing historically recorded medical conditions, symptoms, ailments, and/or asymptomatic conditions and for use by patients for receiving and reviewing medical messages and notifications from medical service providers; Providing temporary use of online non-downloadable software for use by healthcare professionals in registering patients, accessing patient information, entering and viewing patient data and records, analyzing and interpreting patient medical information, managing patient profiles, processing billing, reviewing healthcare insurance information, obtaining customer support services, tracking medical devices used by patients, and/or managing medical device and/or supply inventoryACTIVEApr 25, 2022
044Wellness services, namely, health and medical wellness diagnostic testing, analysis, tracking, and reporting services for others provided via a computer, the Internet, and/or a network of computers; medical testing for diagnostic or treatment purposes, provided via a computer, the Internet, and/or a network of computers; health and wellness testing for lifestyle improvement purposes, provided via a computer, the Internet, and/or a network of computers, namely, health diagnostic testing for identifying the presence, absence, and/or quantity of particular nucleic acids, proteins, organism, or other analytes of interest, for example, in order to test for the presence of one or more pathogens or contaminants in a sample; medical diagnostic reporting, provided via a computer, the Internet, and/or a network of computers; health and wellness diagnostic reporting, provided via a computer, the Internet, and/or a network of computers; health and medical wellness and medical diagnostic counseling services provided via a computer, the Internet, and/or a network of computersACTIVEOct 31, 2011

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 12, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 12, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 2, 2024SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Feb 1, 2024CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jan 10, 2024SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jan 10, 2024DPCCDIVISIONAL PROCESSING COMPLETE—
Nov 9, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 8, 2023INCDITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST—
Oct 30, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 17, 2023IUAFUSE AMENDMENT FILED—
Oct 17, 2023DRRRDIVISIONAL REQUEST RECEIVED—
Oct 17, 2023ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Oct 17, 2023EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 1, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 6, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 6, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 17, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 1, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 1, 2023XAECEXAMINER'S AMENDMENT ENTERED—
May 1, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 1, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
May 1, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 16, 2023ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Apr 4, 2023PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Mar 18, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 18, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Mar 18, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 18, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 18, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 7, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 6, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 6, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 14, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 14, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 14, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 9, 2022DOCKASSIGNED TO EXAMINER—
Mar 3, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—

Frequently asked questions

Related guidance